Artificial Intelligence (AI) in Drug Discovery Market Size, Share & COVID-19 Impact Analysis, By Drug Type (Small Molecule and Large Molecule), By Offering (Software and Services), By Technology (Machine Learning, Natural Language Processing, and Others), By Application (Endocrinology, Cardiology, Oncology, Neurology, and Others), By End-user (Pharmaceutical & Biotechnological Companies, Academic & Research Institutes, and Others), and Regional Forecast, 2023-2030

Last Updated: March 17, 2025 | Format: PDF | Report ID: FBI105354

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2017-2030
Base Year	2022
Estimated Year	2023
Forecast Period	2023-2030
Historical Period	2017-2021
Growth Rate	CAGR of 12.2% from 2023 to 2030
Unit	Value (USD Billion)
Segmentation	By Drug Type, Offering, Technology, Application, End-user, and Region
	By Drug Type Small Molecule Large Molecule
	By Offering Software Services
	By Technology Machine Learning Natural Language Processing Others
	By Application Endocrinology Cardiology Oncology Neurology Others
	By End-user Pharmaceutical & Biotechnological Companies Academic & Research Institutes Others
	By Region North America (By Drug Type, Offering, Technology, Application, End-user, and Country) U.S. Canada Europe (By Drug Type, Offering, Technology, Application, End-user, and Country/Sub-Region) U.K. Germany France Italy Spain Scandinavia Rest of Europe Asia Pacific (By Drug Type, Offering, Technology, Application, End-user, and Country/Sub-Region) Japan China India Australia Southeast Asia Rest of Asia Pacific Latin America (By Drug Type, Offering, Technology, Application, End-user, and Country/Sub-Region) Brazil Mexico Rest of Latin America Middle East & Africa (By Drug Type, Offering, Technology, Application, End-user, and Country/Sub-Region) GCC South Africa Rest of the Middle East & Africa